Inhibitors and Probes of HIV-1 Cell Fusion

$827,494ZIAFY2012DKNIH

National Institute Of Diabetes And Digestive And Kidney Diseases

Investigators

Linked publications & trials

Paper 37552767 Paper 35537058 Paper 29548671 Paper 29306440 Paper 28494151 Paper 28166380 Paper 27783038 Paper 27669574 Paper 27219002 Paper 27114034 Paper 27064278 Paper 26968647 Paper 26577736 Paper 25776945 Paper 25724219 Paper 25105806 Paper 23784792 Paper 23708607 Paper 23470147 Paper 23076586 Paper 22942435 Paper 22788706 Paper 22451932 Paper 22403408 Paper 22113616 Paper 22031945 Paper 21793507 Paper 21667299 Paper 21471192 Paper 21280591 Paper 21085615 Paper 20536175 Paper 20402515 Paper 19856962 Paper 19695655 Paper 19072692 Paper 18952441 Paper 18667502 Paper 18499210 Paper 18183018 Paper 17963357 Paper 17898046 Paper 16952190 Paper 16930043 Paper 16216270 Paper 15937331 Paper 15828842 Paper 15332836 Paper 15209519 Paper 15203162 Paper 14640525 Paper 12757730 Paper 12713335 Paper 12654905 Paper 12538025 Paper 12443092 Paper 12270721 Paper 12161164 Paper 12027767 Paper 11929223 Paper 11916396 Paper 11859089 Paper 11846592 Paper 11591348 Paper 11457139 Paper 11456652 Paper 11418583 Paper 11388862

Abstract

The Natural Products Chemistry Section, LBC, NIDDK has several ongoing projects whose long term aim is to identify and design inhibitors and probes of HIV-1 Envelope-mediated cell fusion. These include the design and development of new gp41-derived peptides and proteins that have dual functions as inhibitors and immunogens, discovery and high resolution structural characterization of new carbohydrate binding proteins that potently inhibit HIV-1 Entry through carbohydrate-mediated interactions with gp120/gp41, discovery of natural product inhibitors of HIV-1 fusion, and structural and mechanistic studies of HIV-1 Envelope - coreceptor interactions.

View original record on NIH RePORTER →